Navigation Links
Alacrita Aggregates the Life Science Practices of Two Consulting Firms and Appoints Simon Turner Ph.D FRSC as Partner
Date:5/8/2013

CAMBRIDGE, Massachusetts, and LONDON, May 8, 2013 /PRNewswire/ --

Alacrita, the transatlantic life sciences consulting firm, has aggregated the life science practices of two consulting firms and appointed Simon Turner PhD FRSC as Partner. Alacrita is taking on the business of Canopus, a specialist life science consulting firm founded by Dr. Turner, which recently acquired the life sciences consulting business of Transentia, which focussed on the commercialisation of early-stage technology.

The move consolidates Alacrita's position as a leading life science consulting firm and expands the firm's partnership to more effectively serve its growing roster of transatlantic clients. Simon has over two decades of experience managing and advising on strategic and product development issues in the life science industry. Over the past ten years, Simon has focused on commercialisation of life science technologies as entrepreneur, executive, venture capital investor and advisor. In 2000, Simon became Chief Executive of Biotica Technology, a venture-capital backed drug-discovery company, which he led for five years. He has since been involved as investor and advisor to biotechnology companies in two investment firms and more recently through Canopus. He gained extensive  strategic management consulting experience in life sciences whilst working at Arthur D Little and Andersen Consulting.

Financial details of the transaction were not disclosed.

Simon Turner said "I am delighted to be joining Alacrita at an exciting stage in its evolution. There are tremendous synergies between our two businesses, in particular, Alacrita's focus on expertise-based consulting through its network of senior consultants with deep expertise and many years of industry experience. Alacrita has consistently demonstrated its ability to deliver real value to sophisticated life science companies and investors who have needed to supplement their internal capability. I look forward to serving the firm's expanding base of clients and building the business into a top tier consulting firm."

Rob Johnson , Partner at Alacrita, said: "We are delighted to welcome Simon to the Alacrita partnership. He is a very experienced management consultant and his strategic insight is rooted in reality, having first-hand experience of leading a biotech company as CEO of Biotica. He has deep and broad technological knowledge of the life science industry and a sound understanding of the challenges faced by senior management. His appointment represents an exciting development for our business and underlines our commitment to providing exceptionally high quality advice to the industry."

Anthony Walker , Partner at Alacrita, added: "Alacrita's consulting practice has been growing on both sides of the Atlantic, and Simon joining the partnership reinforces our capacity to grow further. On a personal note, I have known and worked with Simon at various times over many years, and it is a real pleasure to welcome him to Alacrita."

Notes to Editors

About Alacrita

Alacrita is a rapidly growing management consulting firm providing expertise-based services to the pharmaceutical, biotechnology and life science sectors. The firm is supported by an unrivalled network of experts who operate across the spectrum of life sciences. They combine extensive international industry experience (strategic, technical and commercial), broad functional capabilities and a track record of success across the industry.

Since inception, Alacrita has completed successful consulting projects for big pharma, biotech companies, life science investors, academia and government bodies. Alacrita operates out of offices in London UK and Cambridge MA, USA.

Alacrita UK:
London BioScience Innovation Centre
2 Royal College Street
London, NW1 0NH
Tel: +44-207-691-4915
http://www.alacritaconsulting.com

 

Alacrita US:
One Broadway , 14th floor
Kendall Square
Cambridge, MA 02142
Tel: +1-617-758-4119


For further information, please contact:

Rob Johnson or Anthony Walker at Alacrita
+1-781-249-3324 or +44-771-3402-771



'/>"/>
SOURCE Alacrita
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Alacrita Establishes U.S. Headquarters in Boston Area
2. Provitro Biosciences Awarded First-Ever U.S. Patent For Large-Scale Production Of Bamboo Plants
3. Partnership between EBSCO Publishing and BioOne Online Journals Adds Scholarly Biological, Ecological and Environment Sciences Articles to EBSCO Discovery Serviceā„¢
4. Discovery of Circulating Protein Biomarkers by Analysis of the Tissue Secretome, New Life Science Webinar Hosted by Xtalks
5. Veterinary Bioscience Institute Responds to Demand by Bringing Back Their Most Popular Webinar Series
6. New $40 Million Center for Science and Business Ushers in Cutting-Edge Learning at Monmouth College
7. Challenges and Solutions in Conducting Biosimilar Trials, New Life Science Webinar Hosted by Xtalks
8. MedeAnalytics Ken Perez Predicts Rapid Growth of Healthcare Data Analytics Market at Conference on Data Analytics in Life Sciences, Healthcare and Biotech Companies
9. [Webcast] RateMyProduct, Product Assessment Tool for Life Science Suppliers
10. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
11. Quanta BioSciences qRT-PCR technology recommended in newly published CDC protocol for detection of H7N9 Avian Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... announced the launch of the Supplyframe Design Lab . Located in Pasadena, ... explore the future of how hardware projects are designed, built and brought to ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... YORK , June 23, 2016 ... trading session at 4,833.32, down 0.22%; the Dow Jones Industrial ... S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), ... Therapeutics Inc. (NASDAQ: BIND ). Learn more about ...
Breaking Biology Technology:
(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ...
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... -- Perkotek an innovation leader in attendance control systems is proud to announce the introduction ... to make sure the right employees are actually signing in, and to even control ... ... ... ...
Breaking Biology News(10 mins):